Semaglutide 5mg

Dragon Pharma Semaglutide is a powerful once-weekly GLP-1 RA that significantly reduces HbA1c, body weight, and systolic blood pressure. However, it comes with an increased risk of gastrointestinal adverse events. Further evaluation is needed for pancreatitis and retinopathy in post-approval pharmacovigilance studies.

Belonging to the class of glucagon-like peptide-1 receptor agonists, Semaglutide mimics the GLP-1 hormone released in response to eating. GLP-1 plays a role in stimulating insulin production to lower blood sugar levels. Over the past 15 years, Semaglutide has been utilized in treating Type 2 diabetes.

Moreover, higher levels of GLP-1 interact with the brain to regulate appetite and induce a feeling of fullness. When combined with a balanced diet and exercise, Semaglutide can lead to substantial weight loss, reducing the risk of cancer, diabetes, and heart disease for individuals struggling with obesity or overweight.

Although typically mild, the side effects of Semaglutide such as dizziness, fatigue, gastrointestinal issues, headache, and stomach discomfort should not be disregarded. Starting with a lower dose and gradually increasing it can help mitigate these effects, especially for those new to Semaglutide by Dragon Pharma.

You got a Dragon Pharma Semaglutide vial with 5mg of active substance and if you add there 2ml of bac water and want to use 0.25mg then you will have to inject 10 units from an 1ml 100ui insulin syringe.

Here are numbers for other dosages:
0.25 = 10 units, 0.50 = 20 units, 1.00 = 40 units, 1.70 = 68 units , 2.50 = 100 units.

The math is simple: 5mg of active substance is mixed with 2ml of bac water.
Now in 2ml we have 5mg of active substance. In 1ml = 2.5mg. The 100units insulin syringe is 1ml.

2,5mg / 100units = 0,025mg/unit

0,025mg x 10 units = 0.25mg

Basic Dosage

Weeks 1 - 4 - subcutaneously 0.25mg/week; Weeks 5 - 8 - subcutaneously 0.5mg/week; weeks 9 - 12 - subcutaneously 1mg/week; weeks 13 - 16 - subcutaneously 1.7mg/week;
weeks 17 - subcutaneously 2.4mg/week